AAAAAA

   
Results: 1-9 |
Results: 9
BIOCHEMICAL-DIAGNOSIS OF HEREDITARY HYPERLIPOPROTEINEMIAS
Authors: TVOROGOVA MG ROZHKOVA TA ALIDZHANOVA KG SEMENOVA OA SOBOLEV AV KUKHARCHUK VV TITOV VN
Citation: Mg. Tvorogova et al., BIOCHEMICAL-DIAGNOSIS OF HEREDITARY HYPERLIPOPROTEINEMIAS, Terapevticeskij arhiv, 70(4), 1998, pp. 9-15
EFFECT OF LONG-TERM ENDURACIN MONOTHERAPY ON CLINICOBIOCHEMICAL CHARACTERISTICS OF PATIENTS WITH ISCHEMIC-HEART-DISEASE
Authors: KUKHARCHUK VV SOLOVYEV EY MALYSHEV PP ROZHKOVA TA SEMENOVA OA ARONSKAYA EE
Citation: Vv. Kukharchuk et al., EFFECT OF LONG-TERM ENDURACIN MONOTHERAPY ON CLINICOBIOCHEMICAL CHARACTERISTICS OF PATIENTS WITH ISCHEMIC-HEART-DISEASE, Terapevticeskij arhiv, 69(9), 1997, pp. 41-45
APOLIPOPROTEIN-E AND ACTIVITY OF TRANSPORT OF CHOLESTEROL ESTERS IN TYPE IIA AND IIB HYPERLIPOPROTEINEMIA
Authors: TVOROGOVA MG ROZHKOVA TA SEMENOVA OA LUPANOV VP NURALIEV EY KUKHARCHUK VV TITOV VN
Citation: Mg. Tvorogova et al., APOLIPOPROTEIN-E AND ACTIVITY OF TRANSPORT OF CHOLESTEROL ESTERS IN TYPE IIA AND IIB HYPERLIPOPROTEINEMIA, Terapevticeskij arhiv, 69(12), 1997, pp. 30-33
MONO-VERSUS COMBINED TREATMENT WITH PROBUKOL AND GEMFIBROSIL IN CORONARY HEART-DISEASE PATIENTS WITH HYPERLIPOPROTEINEMIA
Authors: NURALIEV EY LUPANOV VP TVOROGOVA MG LYAKISCHEV AA SEMENOVA OA TITOV VN
Citation: Ey. Nuraliev et al., MONO-VERSUS COMBINED TREATMENT WITH PROBUKOL AND GEMFIBROSIL IN CORONARY HEART-DISEASE PATIENTS WITH HYPERLIPOPROTEINEMIA, Kardiologia, 37(9), 1997, pp. 10-14
COMPARISON OF EFFECTS OF LONG-TERM LIPID- LOWERING DRUG-THERAPY AND OF ITS COMBINATION WITH APHERESIS OF BLOOD-PLASMA LIPIDS ON THE STATE OF CORONARY VESSELS IN PATIENTS WITH HIGH HYPERCHOLESTEROLEMIA AND ISCHEMIC-HEART-DISEASE
Authors: MALYSHEV PP PAVLOV NA LEVITSKY IV TVOROGOVA MG KIVAEVA GM SEMENOVA OA ZARUBA AY KUKHARCHUK VV
Citation: Pp. Malyshev et al., COMPARISON OF EFFECTS OF LONG-TERM LIPID- LOWERING DRUG-THERAPY AND OF ITS COMBINATION WITH APHERESIS OF BLOOD-PLASMA LIPIDS ON THE STATE OF CORONARY VESSELS IN PATIENTS WITH HIGH HYPERCHOLESTEROLEMIA AND ISCHEMIC-HEART-DISEASE, Kardiologia, 37(3), 1997, pp. 26-32
APPLICATION OF THE LIEB MODEL TO DESCRIBE THE CRITICAL-STATE OF A ONE-COMPONENT SYSTEMS
Authors: SOLDATOVA ED SEMENOVA OA
Citation: Ed. Soldatova et Oa. Semenova, APPLICATION OF THE LIEB MODEL TO DESCRIBE THE CRITICAL-STATE OF A ONE-COMPONENT SYSTEMS, Zurnal fiziceskoj himii, 70(5), 1996, pp. 936-938
HYPOLIPIDEMIC DRUG LIPANOR (CIPROFIBRAT) AGAINST PRIMARY HYPERLIPIDEMIA - CLINICAL-EXPERIENCE
Authors: KUKHARCHUK VV ROZHKOVA TA KOTOVA LA TVOROGOVA MG SEMENOVA OA
Citation: Vv. Kukharchuk et al., HYPOLIPIDEMIC DRUG LIPANOR (CIPROFIBRAT) AGAINST PRIMARY HYPERLIPIDEMIA - CLINICAL-EXPERIENCE, Terapevticeskij arhiv, 68(6), 1996, pp. 58-61
PREVALENCE OF ARTERIAL-HYPERTENSION AND I SCHEMIC-HEART-DISEASE IN DIFFERENT TYPES OF DYSLIPOPROTEINEMIA AMONG MEN AGED 20-59 YEARS IN MOSCOW
Authors: TVOROGOVA MG KOSHECHKIN VA ZHUKOVSKY GS PEROVA NV KOSHECHKINA EV SEMENOVA OA ROZHKOVA TA NURBERDYEV D
Citation: Mg. Tvorogova et al., PREVALENCE OF ARTERIAL-HYPERTENSION AND I SCHEMIC-HEART-DISEASE IN DIFFERENT TYPES OF DYSLIPOPROTEINEMIA AMONG MEN AGED 20-59 YEARS IN MOSCOW, Kardiologia, 36(9), 1996, pp. 9-12
ENHANCED EFFECTS OF EXOGENOUS PLASMINOGEN ACTIVATORS ON PLASMA FIBRINCLOT LYSIS AFTER REDUCTION OF ALPHA(2)-PLASMIN INHIBITOR LEVELS BY PLASMA SORPTION
Authors: OGLOBLINA OG SABUROVA OS SEMENOVA OA BELOVA LA
Citation: Og. Ogloblina et al., ENHANCED EFFECTS OF EXOGENOUS PLASMINOGEN ACTIVATORS ON PLASMA FIBRINCLOT LYSIS AFTER REDUCTION OF ALPHA(2)-PLASMIN INHIBITOR LEVELS BY PLASMA SORPTION, Biochemistry, 59(1), 1994, pp. 47-51
Risultati: 1-9 |